in

Basilea Pharmaceutica Ltd. CEO Ronald Scott Retired

Basilea’s CEO Ronald Scott will retire. Chief Commercial Officer David Veitch named as successor. Changes in the Board of Directors

Basel, Switzerland, February 21, 2018 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that Chief Executive Officer Ronald Scott will retire after 18 years with the company. Basilea’s Board of Directors has appointed David Veitch, currently Basilea’s Chief Commercial Officer and member of the Management Committee, to succeed Mr. Scott in the role of Chief Executive Officer effective April 19, 2018.


Name: Ronald Scott

Continent: Europe

Country: Switzerland

Company: Basilea Pharmaceutica Ltd.

Branch: Pharma

Position: CEO

Reason: Retired

Announcement Date: February 20, 2018, 11:00pm

Resignation Date: February 20, 2018, 11:00pm

Source 1: https://globenewswire.com/news-release/2018/02/21/1372305/0/en/Basilea-s-CEO-Ronald-Scott-will-retire-Chief-Commercial-Officer-David-Veitch-named-as-successor-Changes-in-the-Board-of-Directors.html


Add your submission

Image Video Audio Text Embed

This field is required

Drop Images Here

or

You don't have javascript enabled. Media upload is not possible.

Get image from URL

Maximum upload file size: 10 MB.

Processing...

This field is required

Drop Video Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://www.youtube.com/watch?v=WwoKkq685Hk

Add

Supported services:

Maximum upload file size: 20 MB.

Processing...

This field is required

Drop Audio Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://soundcloud.com/community/fellowship-wrapup

Add

Supported services:

Maximum upload file size: 150 MB.

Processing...

This field is required

e.g.: https://www.youtube.com/watch?v=DWYrcnehito

Supported services:

Processing...

Report

What do you think?

Leave a Reply